Neurochemical profile of dementia pugilistica

Journal of Neurotrauma

Volumn 30, Issue 11, 2013, Pages 981-997

  Kokjohn, Tyler A ^a,b   Maarouf, Chera L ^a   Daugs, Ian D ^a   Hunter, Jesse M ^a   Whiteside, Charisse M ^a   Malek Ahmadi, Michael ^a   Rodriguez, Emma ^a,c   Kalback, Walter ^a   Jacobson, Sandra A ^a   Sabbagh, Marwan N ^a   Beach, Thomas G ^a   Roher, Alex E ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

adult brain injury; axonal injury; immunoblots; neurodegenerative disorders; traumatic brain injury

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; DYNEIN ADENOSINE TRIPHOSPHATASE; GLIAL FIBRILLARY ACIDIC PROTEIN; KINESIN; MEMBRANE METALLOENDOPEPTIDASE; TAU PROTEIN;

ADULT; ARTICLE; BIOCHEMISTRY; BOXING; CASE REPORT; CONTROLLED STUDY; DEMENTIA; DEMENTIA PUGILISTICA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MALE; NEUROCHEMISTRY; PROTEIN EXPRESSION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ATHLETIC INJURIES; AUTOPSY; BLOTTING, WESTERN; BOXING; BRAIN; BRAIN INJURIES; CHRONIC DISEASE; DEMENTIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE;

EID: 84879915916     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2012.2699     Document Type: Article

References (127)

1. Martland, H.S. (1928). Punch drunk. JAMA 91, 1103-1107
2. Corsellis, J.A., Bruton, C.J., and Freeman-Browne, D. (1973). The aftermath of boxing. Psychol. Med. 3, 270-303
3. Jordan, B.D. (2000). Chronic traumatic brain injury associated with boxing. Semin. Neurol. 20, 179-185
4. Forstl, H., Haass, C., Hemmer, B., Meyer, B., and Halle, M. (2010 Boxing-acute complications and late sequelae: From concussion to dementia. Dtsch. Arztebl. Int. 107, 835-839
5. Casson, I.R., Siegel, O., Sham, R., Campbell, E.A., Tarlau, M., and DiDomenico, A. (1984). Brain damage in modern boxers. JAMA 251, 2663-2667
6. McKee, A.C., Cantu, R.C., Nowinski, C.J., Hedley-Whyte, E.T., Gavett, B.E., Budson, A.E., Santini, V.E., Lee, H.S., Kubilus, C.A., and Stern, R.A. (2009). Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury. J. Neuropathol. Exp. Neurol. 68, 709-735
7. Saulle, M., and Greenwald, B.D. (2012). Chronic traumatic encephalopathy: A review. Rehabil. Res. Pract. 2012, 816069
8. Stern, R.A., Riley, D.O., Daneshvar, D.H., Nowinski, C.J., Cantu, R.C., and McKee, A.C. (2011). Long-term consequences of repetitive brain trauma: Chronic traumatic encephalopathy. PM. R. 3, Suppl 2, S460-S467
9. Gavett, B.E., Stern, R.A., and McKee, A.C. (2011). Chronic traumatic encephalopathy: A potential late effect of sport-related concussive and subconcussive head trauma. Clin. Sports Med. 30, 179-188, xi
10. Schmidt, M.L., Zhukareva, V., Newell, K.L., Lee, V.M., and Trojanowski, J.Q. (2001). Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol 518-524
11. Lehman, E.J., Hein, M.J., Baron, S.L., and Gersic, C.M. (2012 Neurodegenerative causes of death among retired National Football League players. Neurology 79, 1970-1974
12. Snell, F.I. and Halter, M.J. (2010). A signature wound of war: Mild traumatic brain injury. J. Psychosoc. Nurs. Ment. Health Serv. 48, 22-28
13. Wojcik, B.E., Stein, C.R., Bagg, K., Humphrey, R.J., and Orosco, J. (2010). Traumatic brain injury hospitalizations of U.S. army soldiers deployed to Afghanistan and Iraq. Am. J. Prev. Med. 38, Suppl 1, S108-S116
14. Hoge, C.W., McGurk, D., Thomas, J.L., Cox, A.L., Engel, C.C., and Castro, C.A. (2008). Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N. Engl. J. Med. 358, 453-463
15. Heyman, A., Wilkinson, W.E., Stafford, J.A., Helms, M.J., Sigmon, A.H., and Weinberg, T. (1984). Alzheimer's disease: A study of epidemiological aspects. Ann. Neurol. 15, 335-341
16. Amaducci, L.A., Fratiglioni, L., Rocca, W.A., Fieschi, C., Livrea, P., Pedone, D., Bracco, L., Lippi, A., Gandolfo, C., Bino, G., Prencipe, M., Bonattim, M.L., Carella, F., Tavolato, B., Ferla, S., Lenzi, G.L., Grigoletto, F., and Schoenberg, B.S. (1986). Risk factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population. Neurology 36, 922-931
17. Mortimer, J.A., van Duijn, C.M., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., Jorm, A.F., Kokmen, E., Kondo, K., Rocca, W.A., Shalat, S.L., Soininen, H., and Hofman, A. (1991). Head trauma as a risk factor for Alzheimer's disease: A collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20, Suppl 2, S28-S35
18. Gualtieri, T., and Cox, D.R. (1991). The delayed neurobehavioural sequelae of traumatic brain injury. Brain Inj. 5, 219-232
19. Clinton, J., Ambler, M.W., and Roberts, G.W. (1991). Post-traumatic Alzheimer's disease: Preponderance of a single plaque type. Neuropathol. Appl. Neurobiol. 17, 69-74
20. Breteler, M.M., Claus, J.J., van Duijn, C.M., Launer, L.J., and Hofman, A. (1992). Epidemiology of Alzheimer's disease. Epidemiol. Rev. 14, 59-82
21. Mayeux, R., Ottman, R., Tang, M.X., Noboa-Bauza, L., Marder, K., Gurland, B., and Stern, Y. (1993). Genetic susceptibility and head injury as risk factors for Alzheimer's disease among communitydwelling elderly persons and their first-degree relatives. Ann. Neurol. 33, 494-501
22. McKee, A.C., Gavett, B.E., Stern, R.A., Nowinski, C.J., Cantu, R.C., Kowall, N.W., Perl, D.P., Hedley-Whyte, E.T., Price, B., Sullivan, C., Morin, P., Lee, H.S., Kubilus, C.A., Daneshvar, D.H., Wulff, M., and Budson, A.E. (2010). TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 69, 918-929
23. Costanza, A., Weber, K., Gandy, S., Bouras, C., Hof, P.R., Giannakopoulos, P., and Canuto, A. (2011). Review: Contact sport-related chronic traumatic encephalopathy in the elderly: Clinical expression and structural substrates. Neuropathol. Appl. Neurobiol. 37, 570-584
24. Ikonomovic, M.D., Uryu, K., Abrahamson, E.E., Ciallella, J.R., Trojanowski, J.Q., Lee, V.M., Clark, R.S., Marion, D.W., Wisniewski, S.R., and Dekosky, S.T. (2004). Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 190, 192-203
25. Uryu, K., Chen, X.H., Martinez, D., Browne, K.D., Johnson, V.E., Graham, D.I., Lee, V.M., Trojanowski, J.Q., and Smith, D.H. (2007 Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp. Neurol. 208, 185-192
26. Roberts, G.W., Allsop, D., and Bruton, C. (1990). The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiatry 53, 373-378
27. Tokuda, T., Ikeda, S., Yanagisawa, N., Ihara, Y., and Glenner, G.G. (1991). Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol. 82, 280-285
28. Geddes, J.F., Vowles, G.H., Nicoll, J.A., and Revesz, T. (1999 Neuronal cytoskeletal changes are an early consequence of repetitive head injury. Acta Neuropathol. 98, 171-178
29. Rauramaa, T., Pikkarainen, M., Englund, E., Ince, P.G., Jellinger, K., Paetau, A., and Alafuzoff, I. (2011). TAR-DNA binding protein-43 and alterations in the hippocampus. J. Neural Transm. 118, 683-689
30. Davidson, Y.S., Raby, S., Foulds, P.G., Robinson, A., Thompson, J.C., Sikkink, S., Yusuf, I., Amin, H., DuPlessis, D., Troakes, C., Al-Sarraj, S., Sloan, C., Esiri, M.M., Prasher, V.P., Allsop, D., Neary, D., Pickering-Brown, S.M., Snowden, J.S., and Mann, D.M. (2011 TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: Association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol. 122, 703-713
31. Graham, D.I., Gentleman, S.M., Nicoll, J.A., Royston, M.C., McKenzie, J.E., Roberts, G.W., Mrak, R.E., and Griffin, W.S. (1999). Is there a genetic basis for the deposition of beta-amyloid after fatal head injury? Cell Mol. Neurobiol. 19, 19-30
32. Marklund, N., Blennow, K., Zetterberg, H., Ronne-Engstrom, E., Enblad, P., and Hillered, L. (2009). Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury. J. Neurosurg. 110, 1227-1237
33. Brody, D.L., Magnoni, S., Schwetye, K.E., Spinner, M.L., Esparza, T.J., Stocchetti, N., Zipfel, G.J., and Holtzman, D.M beta dynamics correlate with neurological status in the injured human brain. Science 321, 1221-1224
34. Roberts, G.W., Gentleman, S.M., Lynch, A., and Graham, D.I. (1991). beta A4 amyloid protein deposition in brain after head trauma. Lancet 338, 1422-1423
35. Roberts, G.W., Gentleman, S.M., Lynch, A., Murray, L., Landon, M., and Graham, D.I. (1994). Beta amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 57, 419-425
36. Gentleman, S.M., Greenberg, B.D., Savage, M.J., Noori, M., Newman, S.J., Roberts, G.W., Griffin, W.S., and Graham, D.I. (1997). A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport 8, 1519-1522
37. Olsson, A., Csajbok, L., Ost, M., Hoglund, K., Nylen, K., Rosengren, L., Nellgard, B., and Blennow, K. (2004). Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. J. Neurol. 251, 870-876
38. Saing, T., Dick, M., Nelson, P.T., Kim, R.C., Cribbs, D.H., and Head, E. (2012). Frontal cortex neuropathology in dementia pugilistica. J. Neurotrauma 29, 1054-1070
39. Chen, X.H., Siman, R., Iwata, A., Meaney, D.F., Trojanowski, J.Q., and Smith, D.H. (2004). Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am. J. Pathol. 165, 357-371
40. Xiong, Y., Peterson, P.L., and Lee, C.P. (2001). Alterations in cerebral energy metabolism induced by traumatic brain injury. Neurol. Res. 23, 129-138
41. Park, E., Bell, J.D., and Baker, A.J (2008). Traumatic brain injury: Can the consequences be stopped? CMAJ. 178, 1163-1170
42. Barkhoudarian, G., Hovda, D.A., and Giza, C.C. (2011). The molecular pathophysiology of concussive brain injury. Clin. Sports Med. 30, 33-48, vii-iii
43. Beach, T.G., Sue, L.I., Walker, D.G., Roher, A.E., Lue, L., Vedders, L., Connor, D.J., Sabbagh, M.N., and Rogers, J. (2008). The Sun Health Research Institute Brain Donation Program: Description and experience, 1987-2007. Cell Tissue Bank. 9, 229-245
44. Sabbagh, M.N., Cooper, K., DeLange, J., Stoehr, J.D., Thind, K., Lahti, T., Reisberg, B., Sue, L., Vedders, L., Fleming, S.R., and Beach, T.G. (2010). Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD. Curr. Alzheimer Res. 7, 280-286
45. Roher, A.E., Esh, C., Kokjohn, T.A., Kalback, W., Luehrs, D.C., Seward, J.D., Sue, L.I., and Beach, T.G. (2003). Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler. Thromb. Vasc. Biol. 23, 2055-2062
46. Maarouf, C.L., Daugs, I.D., Kokjohn, T.A., Walker, D.G., Hunter, J.M., Kruchowsky, J.C., Woltjer, R., Kaye, J., Castano, E.M., Sabbagh, M.N., Beach, T.G., and Roher, A.E. (2011). Alzheimer's disease and non-demented high pathology control nonagenarians: Comparing and contrasting the biochemistry of cognitively successful aging. PLoS. One. 6, e27291
47. Van Paesschen, W., Revesz, T., and Duncan, J.S. (1997). Corpora amylacea in hippocampal sclerosis. J. Neurol. Neurosurg. Psychiatry 63, 513-515
48. McD Anderson, R., and Opeskin, K. (1998). Timing of early changes in brain trauma. Am. J. Forensic Med. Pathol. 19, 1-9
49. Schenker, M., and Birch, R. (2001). Diagnosis of the level of intradural rupture of the rootlets in transaction lesions of the brachial plexus. J. Bone Joint Surg. Br. 83, 916-920
50. Kuchna, I., and Kozlowski, P.B. (1991). Sequelae of perinatal central nervous system damage after long-term survival. Neuropatol. Pol. 29, 103-108
51. Jellinger, K.A. (2004). Head injury and dementia. Curr. Opin. Neurol. 17, 719-723
52. Graham, D.I., Gentleman, S.M., Nicoll, J.A., Royston, M.C., McKenzie, J.E., Roberts, G.W., and Griffin, W.S. (1996). Altered beta-APP metabolism after head injury and its relationship to the aetiology of Alzheimer's disease. Acta Neurochir. Suppl 66, 96-102
53. Smith, D.H., Chen, X.H., Iwata, A., and Graham, D.I. (2003 Amyloid beta accumulation in axons after traumatic brain injury in humans. J. Neurosurg. 98, 1072-1077
54. Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.J., Hama, E., Sekine-Aizawa, Y., and Saido, T.C. (2000). Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143-150
55. Hersh, L.B., and Rodgers, D.W. (2008). Neprilysin and amyloid beta peptide degradation. Curr. Alzheimer Res. 5, 225-231
56. Chen, X.H., Johnson, V.E., Uryu, K., Trojanowski, J.Q., and Smith, D.H. (2009). A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol. 19, 214-223
57. Johnson, V.E., Stewart, W., Graham, D.I., Stewart, J.E., Praestgaard, A.H., and Smith, D.H (2009). A neprilysin polymorphism and amyloid- beta plaques following traumatic brain injury. J. Neurotrauma 26, 1197-1202
58. Teasdale, G.M., Nicoll, J.A., Murray, G., and Fiddes, M. (1997 Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350, 1069-1071
59. Thal, D.R., Capetillo-Zarate, E., Schultz, C., Rub, U., Saido, T.C., Yamaguchi, H., Haass, C., Griffin, W.S., Del Tredici, K., Braak, H., and Ghebremedhin, E. (2005). Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotypedependent manner. Acta Neuropathol. 110, 459-471
60. Horsburgh, K., Cole, G.M., Yang, F., Savage, M.J., Greenberg, B.D., Gentleman, S.M., Graham, D.I., and Nicoll, J.A (2000). beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury. Neuropathol. Appl. Neurobiol. 26, 124-132
61. Johnson, V.E., Stewart, W., and Smith, D.H. (2010). Traumatic brain injury and amyloid-beta pathology: A link to Alzheimer's disease? Nat. Rev. Neurosci. 11, 361-370
62. Dekosky, S.T., Abrahamson, E.E., Ciallella, J.R., Paljug, W.R., Wisniewski, S.R., Clark, R.S., and Ikonomovic, M.D. (2007). Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch. Neurol. 64, 541-544
63. Sherriff, F.E., Bridges, L.R., Gentleman, S.M., Sivaloganathan, S., and Wilson, S. (1994). Markers of axonal injury in post mortem human brain. Acta Neuropathol. 88, 433-439
64. Thornton, E., Vink, R., Blumbergs, P.C., and Van Den Heuvel, C. (2006). Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res. 1094, 38-46
65. Gowing, E., Roher, A.E., Woods, A.S., Cotter, R.J., Chaney, M., Little, S.P., and Ball, M.J. (1994). Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J. Biol. Chem. 269, 10987-10990
66. Kokjohn, T.A., Maarouf, C.L., and Roher, A.E. (2012). Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray? Alzheimers Dement. 8, 574-583
67. Cullen, K.M., Kocsi, Z., and Stone, J. (2006). Microvascular pathology in the aging human brain: Evidence that senile plaques are sites of microhaemorrhages. Neurobiol. Aging 27, 1786-1796
68. Stone, J. (2008). What initiates the formation of senile plaques? The origin of Alzheimer-like dementias in capillary haemorrhages. Med. Hypotheses 71, 347-359
69. Robinson, S.R. and Bishop, G.M. (2002). Abeta as a bioflocculant: Implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol. Aging 23, 1051-1072
70. Bishop, G.M. and Robinson, S.R. (2004). The amyloid paradox: Amyloid-beta-metal complexes can be neurotoxic and neuroprotective. Brain Pathol. 14, 448-452
71. Wu, C.W., Liao, P.C., Yu, L., Wang, S.T., Chen, S.T., Wu, C.M., and Kuo, Y.M. (2004). Hemoglobin promotes Abeta oligomer formation and localizes in neurons and amyloid deposits. Neurobiol. Dis. 17, 367-377
72. Chuang, J.Y., Lee, C.W., Shih, Y.H., Yang, T., Yu, L., and Kuo, Y.M. (2012). Interactions between amyloid-beta and hemoglobin: Implications for amyloid plaque formation in Alzheimer's disease. PLoS. One. 7, e33120
73. Paris, D., Humphrey, J., Quadros, A., Patel, N., Crescentini, R., Crawford, F., and Mullan, M. (2003). Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: Role of inflammation. Neurol. Res. 25, 642-651
74. Crawford, F., Suo, Z., Fang, C., Sawar, A., Su, G., Arendash, G., and Mullan, M. (1997). The vasoactivity of A beta peptides. Ann. N. Y. Acad. Sci. 826, 35-46
75. Paris, D., Townsend, K., Quadros, A., Humphrey, J., Sun, J., Brem, S., Wotoczek-Obadia, M., DelleDonne, A., Patel, N., Obregon, D.F., Crescentini, R., Abdullah, L., Coppola, D., Rojiani, A.M., Crawford, F., Sebti, S.M., and Mullan, M. (2004). Inhibition of angiogenesis by Abeta peptides. Angiogenesis 7, 75-85
76. Johnston, H., Boutin, H., and Allan, S.M. (2011). Assessing the contribution of inflammation in models of Alzheimer's disease. Biochem. Soc. Trans. 39, 886-890
77. Breydo, L., Wu, J.W., and Uversky, V.N. (2012). A-synuclein misfolding and Parkinson's disease. Biochim. Biophys. Acta 1822, 261-285
78. Desplats, P., Lee, H.J., Bae, E.J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., and Lee, S.J. (2009). Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. U. S. A 106, 13010-13015
79. Newell, K.L., Boyer, P., Gomez-Tortosa, E., Hobbs, W., Hedley-Whyte, E.T., Vonsattel, J.P., and Hyman, B.T. (1999). Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury. J. Neuropathol. Exp. Neurol. 58, 1263-1268
80. Su, E., Bell, M.J., Wisniewski, S.R., Adelson, P.D., Janesko-Feldman, K.L., Salonia, R., Clark, R.S., Kochanek, P.M., Kagan, V.E., and Bayir, H. (2010). alpha-Synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: The effect of therapeutic hypothermia. Dev. Neurosci. 32, 385-395
81. Goedert, M. and Jakes, R. (1990). Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 9, 4225-4230
82. Goux, W.J., Liu, B., Shumburo, A.M., Parikh, S., and Sparkman, D.R. (2001). A quantitative assessment of glycolipid and protein associated with paired helical filament preparations from Alzheimer's diseased brain. J. Alzheimers Dis. 3, 455-466
83. Goux, W.J., Rodriguez, S., and Sparkman, D.R. (1995). Analysis of the core components of Alzheimer paired helical filaments. A gas chromatography/mass spectrometry characterization of fatty acids, carbohydrates and long-chain bases. FEBS Lett. 366, 81-85
84. Sparkman, D.R., Goux, W.J., Jones, C.M., White, C.L., III, and Hill, S.J. (1991). Alzheimer disease paired helical filament core structures contain glycolipid. Biochem. Biophys. Res. Commun. 181, 771-779
85. Thomas, S.N., Funk, K.E., Wan, Y., Liao, Z., Davies, P., Kuret, J., and Yang, A.J. (2012). Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: A mass spectrometry approach. Acta Neuropathol. 123, 105-117
86. Martin, L., Latypova, X., and Terro, F. (2011). Post-translational modifications of tau protein: Implications for Alzheimer's disease. Neurochem. Int. 58, 458-471
87. Binder, D.K. and Scharfman, H.E. (2004). Brain-derived neurotrophic factor. Growth Factors 22, 123-131
88. Nagahara, A.H., and Tuszynski, M.H. (2011). Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat. Rev. Drug Discov. 10, 209-219
89. Griesbach, G.S., Hovda, D.A., Molteni, R., Wu, A., and Gomez-Pinilla, F. (2004). Voluntary exercise following traumatic brain injury: Brain-derived neurotrophic factor upregulation and recovery of function. Neuroscience 125, 129-139
90. Kaplan, G.B., Vasterling, J.J., and Vedak, P.C. (2010). Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: Role in pathogenesis and treatment. Behav. Pharmacol. 21, 427-437
91. Ma, H., Yu, B., Kong, L., Zhang, Y., and Shi, Y. (2012). Neural stem cells over-expressing brain-derived neurotrophic factor (BDNF) stimulate synaptic protein expression and promote functional recovery following transplantation in rat model of traumatic brain injury. Neurochem. Res. 37, 69-83
92. Mouser, P.E., Head, E., Ha, K.H., and Rohn, T.T. (2006). Caspasemediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Am. J. Pathol. 168, 936-946
93. Hol, E.M., Roelofs, R.F., Moraal, E., Sonnemans, M.A., Sluijs, J.A., Proper, E.A., de Graan, P.N., Fischer, D.F., and van Leeuwen, F.W. (2003). Neuronal expression of GFAP in patients with Alzheimer pathology and identification of novel GFAP splice forms. Mol. Psychiatry 8, 786-796
94. Korolainen, M.A., Auriola, S., Nyman, T.A., Alafuzoff, I., and Pirttila, T. (2005). Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain. Neurobiol. Dis. 20, 858-870
95. Porchet, R., Probst, A., Bouras, C., Draberova, E., Draber, P., and Riederer, B.M. (2003). Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease. Proteomics 3, 1476-1485
96. Inagaki, M., Nakamura, Y., Takeda, M., Nishimura, T., and Inagaki, N. (1994). Glial fibrillary acidic protein: Dynamic property and regulation by phosphorylation. Brain Pathol. 4, 239-243
97. Cervos-Navarro, J. and Lafuente, J.V. (1991). Traumatic brain injuries: Structural changes. J. Neurol. Sci. 103, Suppl, S3-S14
98. Schachtrup, C., Ryu, J.K., Helmrick, M.J., Vagena, E., Galanakis, D.K., Degen, J.L., Margolis, R.U., and Akassoglou, K. (2010 Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage. J. Neurosci. 30, 5843-5854
99. Bovolenta, P., Wandosell, F., and Nieto-Sampedro, M. (1992). CNS glial scar tissue: A source of molecules which inhibit central neurite outgrowth. Prog. Brain Res. 94, 367-379
100. Hatten, M.E., Liem, R.K., Shelanski, M.L., and Mason, C.A. (1991 Astroglia in CNS injury. Glia 4, 233-243
101. Rudge, J.S. and Silver, J. (1990). Inhibition of neurite outgrowth on astroglial scars in vitro. J. Neurosci. 10, 3594-3603
102. Snow, D.M., Lemmon, V., Carrino, D.A., Caplan, A.I., and Silver, J. (1990). Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp. Neurol. 109, 111-130
103. Eng, L.F., Ghirnikar, R.S., and Lee, Y.L. (2000). Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25, 1439-1451
104. McGraw, J., Hiebert, G.W., and Steeves, J.D. (2001). Modulating astrogliosis after neurotrauma. J. Neurosci. Res. 63, 109-115
105. Pekny, M. and Nilsson, M. (2005). Astrocyte activation and reactive gliosis. Glia 50, 427-434
106. Zurek, J. and Fedora, M. (2011). Dynamics of glial fibrillary acidic protein during traumatic brain injury in children. J. Trauma71, 854-859
107. Honda, M., Tsuruta, R., Kaneko, T., Kasaoka, S., Yagi, T., Todani, M., Fujita, M., Izumi, T., and Maekawa, T. (2010). Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J. Trauma 69, 104-109
108. Lumpkins, K.M., Bochicchio, G.V., Keledjian, K., Simard, J.M., McCunn, M., and Scalea, T. (2008). Glial fibrillary acidic protein is highly correlated with brain injury. J. Trauma 65, 778-784
109. Neselius, S., Brisby, H., Theodorsson, A., Blennow, K., Zetterberg, H., and Marcusson, J. (2012). CSF-biomarkers in Olympic boxing: Diagnosis and effects of repetitive head t rauma. PLoS. One. 7, e33606
110. Zetterberg, H., Hietala, M.A., Jonsson, M., Andreasen, N., Styrud, E., Karlsson, I., Edman, A., Popa, C., Rasulzada, A., Wahlund, L.O., Mehta, P.D., Rosengren, L., Blennow, K., and Wallin, A. (2006 Neurochemical aftermath of amateur boxing. Arch. Neurol. 63, 1277-1280
111. Hirokawa, N., Niwa, S., and Tanaka, Y. (2010). Molecular motors in neurons: Transport mechanisms and roles in brain function, development, and disease. Neuron 68, 610-638
112. McAllister, T.W. (2011). Neurobiological consequences of traumatic brain injury. Dialogues Clin. Neurosci. 13, 287-300
113. Johnson, V.E., Stewart, W., and Smith, D.H. (2012). Axonal pathology in traumatic brain injury. Exp. Neurol. Epub ahead of print
114. Xiaoshengi, H., Guitao, Y., Xiang, Z., and Zhou, F. (2010). A morphological study of diffuse axonal injury in a rat model by lateral head rotation trauma. Acta Neurol. Belg. 110, 49-56
115. Shitaka, Y., Tran, H.T., Bennett, R.E., Sanchez, L., Levy, M.A., Dikranian, K., and Brody, D.L. (2011). Repetitive closed-skull traumatic brain injury in mice causes persistent multifocal axonal injury and microglial reactivity. J. Neuropathol. Exp. Neurol. 70, 551-567
116. Tang-Schomer, M.D., Johnson, V.E., Baas, P.W., Stewart, W., and Smith, D.H. (2012). Partial interruption of axonal transport due to microtubule breakage accounts for the formation of periodic varicosities after traumatic axonal injury. Exp. Neurol. 233, 364- 372
117. Christman, C.W., Grady, M.S., Walker, S.A., Holloway, K.L., and Povlishock, J.T. (1994). Ultrastructural studies of diffuse axonal injury in humans. J. Neurotrauma 11, 173-186
118. Castejon, O.J. (1985). Electron microscopic study of central axons degeneration in traumatic human brain edema. J. Submicrosc. Cytol. 17, 703-718
119. Castejon, O.J. (1998). Electron microscopic analysis of cortical biopsies in patients with traumatic brain injuries and dysfunction of neurobehavioural system. J. Submicrosc. Cytol. Pathol. 30, 145-156
120. Castejon, O.J., and Acurero, G. (2004). Traumatic axolemmal and cytoskeletal derangement in myelinated axons of human oedematous cerebral cortex and loss of consciousness. An electron microscopic study using cortical biopsies. J. Submicrosc. Cytol. Pathol. 36, 285-293
121. Meythaler, J.M., Peduzzi, J.D., Eleftheriou, E., and Novack, T.A. (2001). Current concepts: Diffuse axonal injury-associated traumatic brain injury. Arch. Phys. Med. Rehabil. 82, 1461-1471
122. Reeves, T.M., Smith, T.L., Williamson, J.C., and Phillips, L.L. (2012). Unmyelinated axons show selective rostrocaudal pathology in the corpus callosum after traumatic brain injury. J. Neuropathol. Exp. Neurol. 71, 198-210
123. Roher, A.E., Weiss, N., Kokjohn, T.A., Kuo, Y.M., Kalback, W., Anthony, J., Watson, D., Luehrs, D.C., Sue, L., Walker, D., Emmerling, M., Goux, W., and Beach, T. (2002). Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 41, 11080-11090
124. Kalback, W., Esh, C., Castano, E.M., Rahman,A., Kokjohn, T., Luehrs, D.C., Sue, L., Cisneros, R., Gerber, F., Richardson, C., Bohrmann, B., Walker, D.G., Beach, T.G., and Roher, A.E. (2004). Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol. Res. 26, 525-539
125. Bartzokis, G. (2011). Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 32, 1341-1371
126. Liao, M.C., Hoos, M.D., Aucoin, D., Ahmed, M., Davis, J., Smith, S.O., and Van Nostrand, W.E. (2010). N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly. J. Biol. Chem. 285, 35590-35598
127. Liao, M.C., Ahmed, M., Smith, S.O., and Van Nostrand, W.E. (2009). Degradation of amyloid beta protein by purified myelin basic protein. J. Biol. Chem. 284, 28917-28925